About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Sanyou and KangaBio to collaborate on antibody drug development and innovation

Swedish researchers developing new treatment for chronic hepatitis B and D infections

Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics

Ordaōs raises $5M to accelerate drug design and discovery

3T Biosciences launches with $40M financing

Scottish researchers can tap into new £300K fund

ADVERTISEMENT

New drug boosts options for rheumatoid arthritis treatment

KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever

Ilya Pharma finalizes global patent coverage for modified lactic acid bacteria to treat wounds

Hera Biotech bags $1.9M for endometriosis diagnostic test

Study findings could lead to new anti-cancer drugs

Potential new treatment for angioimmunoblastic T-cell lymphoma?

ADVERTISEMENT